Clinical trials
Phase 1/2 Purpura, Thrombocytopenic, Idiopathic trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2021 | 1 |
| 2024 | 1 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Unknown status | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peking University People's Hospital | 3 |
| 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China | 1 |
| Eli Lilly and Company | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Jiangsu BioJeTay Biotechnology Co., Ltd. | 1 |
| Keymed Biosciences Co.Ltd | 1 |
| Kyowa Kirin China Pharmaceutical Co., Ltd. | 1 |
| Shanghai Escugen Biotechnology Co., Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Purpura, Thrombocytopenic, Idiopathic | 10 |
| Anemia, Hemolytic, Autoimmune | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.